Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer

C Francavilla, CS O'Brien - Open Biology, 2022 - royalsocietypublishing.org
Fibroblast Growth Factor Receptor (FGFR) signalling plays a critical role in breast embryonal
development, tissue homeostasis, tumorigenesis and metastasis. FGFR, its numerous FGF …

FGFR families: biological functions and therapeutic interventions in tumors

Q Liu, J Huang, W Yan, Z Liu, S Liu, W Fang - MedComm, 2023 - Wiley Online Library
There are five fibroblast growth factor receptors (FGFRs), namely, FGFR1–FGFR5. When
FGFR binds to its ligand, namely, fibroblast growth factor (FGF), it dimerizes and …

[HTML][HTML] Effects of Klotho on fibrosis and cancer: a renal focus on mechanisms and therapeutic strategies

R Mencke, H Olauson, JL Hillebrands - Advanced drug delivery reviews, 2017 - Elsevier
Klotho is a membrane-bound protein predominantly expressed in the kidney, where it acts
as a permissive co-receptor for Fibroblast Growth Factor 23. In its shed form, Klotho exerts …

Fibroblast growth factor receptor 4 targeting in cancer: new insights into mechanisms and therapeutic strategies

L Lang, Y Teng - Cells, 2019 - mdpi.com
Fibroblast growth factor receptor 4 (FGFR4), a tyrosine kinase receptor for FGFs, is involved
in diverse cellular processes, including the regulation of cell proliferation, differentiation …

Tissue expression and source of circulating αKlotho

H Olauson, R Mencke, JL Hillebrands, TE Larsson - Bone, 2017 - Elsevier
Abstract αKlotho (Klotho), a type I transmembrane protein and a coreceptor for Fibroblast
Growth Factor-23, was initially thought to be expressed only in a limited number of tissues …

Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression

Y Liu, M Cao, Y Cai, X Li, C Zhao, R Cui - Frontiers in cell and …, 2020 - frontiersin.org
Fibroblast growth factor (FGF) receptor 4 (FGFR4) belongs to a family of tyrosine kinase
receptor. FGFR4 is highly activated in certain types of cancer and its activation is closely …

FGFR4: A promising therapeutic target for breast cancer and other solid tumors

KM Levine, K Ding, L Chen, S Oesterreich - Pharmacology & therapeutics, 2020 - Elsevier
The fibroblast growth factor receptor (FGFR) signaling pathway has long been known to
cancer researchers because of its role in cell survival, proliferation, migration, and …

Role of fibroblast growth factor 23 (FGF23) and αKlotho in cancer

F Ewendt, M Feger, M Föller - Frontiers in Cell and Developmental …, 2021 - frontiersin.org
Together with fibroblast growth factors (FGFs) 19 and 21, FGF23 is an endocrine member of
the family of FGFs. Mainly secreted by bone cells, FGF23 acts as a hormone on the kidney …

[HTML][HTML] Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival

KH Tiong, BS Tan, HL Choo, FFL Chung, LW Hii… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Basal-like breast cancer is an aggressive tumor subtype with poor prognosis. The discovery
of underlying mechanisms mediating tumor cell survival, and the development of novel …

FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression

X Zhao, F Xu, NP Dominguez, Y Xiong… - Molecular …, 2018 - Wiley Online Library
Although genetic amplification and overexpression of the fibroblast growth factor 19 (FGF19)
gene are found in human breast cancer, mechanisms that contribute to such functional …